Purpose: There is a lack of information from South America regarding factors that predict the clinical outcomes of patients treated medically for mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). This study was conducted to determine which of these factors are the most important.
Methods: This study included 110 South American patients with MTLE-HS treated with antiepileptic drugs.